1 |
Production of a bispecific antibody targeting TNF-alpha and C5a in Pichia pastoris and its therapeutic potential in rheumatoid arthritis Chen J, He ZH, Fan YR, Zhou XD, Li LJ, Liu MY Biotechnology Letters, 42(4), 557, 2020 |
2 |
Effective suppression of C5a-induced proinflammatory response using anti-human C5a repebody Hwang DE, Choi JM, Yang CS, Lee JJ, Heu W, Jo EK, Kim HS Biochemical and Biophysical Research Communications, 477(4), 1072, 2016 |
3 |
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs Szebeni J, Storm G Biochemical and Biophysical Research Communications, 468(3), 490, 2015 |
4 |
A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions Dechavanne V, Barrillat N, Borlat F, Hermant A, Magnenat L, Paquet M, Antonsson B, Chevalet L Protein Expression and Purification, 75(2), 192, 2011 |
5 |
Expression of soluble proteins in Escherichia coli by linkage with the acidic propiece of eosinophil major basic protein DiScipio RG, Khaldoyanidi SK, Schraufstatter IU Protein Expression and Purification, 79(1), 72, 2011 |
6 |
Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor Nikiforovich GV, Baranski TJ Biochemical and Biophysical Research Communications, 390(3), 481, 2009 |
7 |
Single amino acid of G(alpha 16) (Ala(228)) is responsible for the ability of chemoattractant C5a receptor to induce G(alpha 16)-mediated inositol phosphate release Ha JH, Dhanasekaran N, Koh HC, Lee CH Biochemical and Biophysical Research Communications, 278(2), 426, 2000 |
8 |
Impaired Mast Cell-Dependent Natural Immunity in Complement C3-Deficient Mice Prodeus AP, Zhou XN, Maurer M, Galli SJ, Carroll MC Nature, 390(6656), 172, 1997 |